Approval · Notice of Compliance 27725 · 2022
JUXTAPID: Notice of Compliance 27725
Issued March 7, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27725
- Date
- March 7, 2022
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph Conversion of the Product Monograph to 2020 format Update to the inner and outer labels Update to the package insert
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| JUXTAPID | Not yet assigned | — |
Medicinal ingredients
- LOMITAPIDE MESYLATE 5 MG per CAP
- LOMITAPIDE MESYLATE 10 MG per CAP
- LOMITAPIDE MESYLATE 20 MG per CAP